FDA Issues Medical Device Safety Action Plan

Article

The Center for Devices and Radiological Health (CDRH)’s vision for medical device safety is to protect patients and spur innovation of new products that are safer, more effective, and address unmet medical needs.

Providing patients with access to safe medical devices that meet their healthcare needs remains a top Food and Drug Administration (FDA) priority. The Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health outlines how the agency will encourage innovation to improve safety, detect safety risks earlier, and keep doctors and patients better informed.

In the Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health, the FDA describes key actions it will take in the following areas:

- Establish a robust medical device patient safety net in the United States
- Explore regulatory options to streamline and modernize timely implementation of post-market mitigations
- Spur innovation towards safer medical devices
- Advance medical device cybersecurity
- Integrate CDRH's pre-market and post-market offices and activities to advance the use of a Total Product Life Cycle (TPLC) approach to device safety

The FDA is modernizing measures to improve the safety of medical devices while continuing to create more efficient pathways to bring lifesaving devices to patients.

To access the report, CLICK HERE.

Source: FDA

Recent Videos
Cameron Memorial Community Hospital Series With ICT
Ambassador Deborah L. Birx, MD, senior fellow of the George W. Bush Presidential Center
Cameron Memorial Community Hospital series with ICT  (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT  (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Isis Lamphier, MPH, MHA, CIC; Tori Whitacre Martonicz, MA; and Heather Stoltzfus, MPH, RN, CIC, at APIC Conference and Expo 2024 (Photo courtesy of Tori Whitacre Martonicz)
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Related Content